monoclonal-antibodies

Documents about monoclonal-antibodies

• XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures.#738NCBI PubMed Central
• Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.#18484NCBI PubMed Central
• Monoclonal antibodies targeting the rabies virus glycoprotein promotes viral clearance and Fc-dependent neuroprotection in the infected brain#370665HAL (France)
• Identification and characterization of new B cell epitopes on the nucleocapsid protein of bovine coronavirus using monoclonal antibodies.#439112NCBI PubMed Central
• Use of Radioactive Ion Beams for Biomedical Research 1. in vivo labelling of monoclonal antibodies with radio-lanthanides and $^{225}$Ac#640593CERN CDS
• Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis#978875ClinicalTrials.gov
• Production Of Monoclonal Antibodies Against Activin A Receptor Type Ii Like Kinase 1 (Alk-1) By Phage Display#225744USM Repository
• Persistent rise in device-related errors for CGRP monoclonal antibodies: impact of the COVID-19 pandemic and post-pandemic implications.#368247NCBI PubMed Central
• Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life#644265IRIS
• Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study#684639Europe PMC
• A Study of Ramucirumab or Icrucumab in Colorectal Cancer#874051ClinicalTrials.gov
• Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy#992747ClinicalTrials.gov
• Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.#672217Repisalud
• A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the Colon#907731ClinicalTrials.gov
• ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice.#315447NCBI PubMed Central
• Elranatamab: A novel B-cell maturation T-cell engager#642684Europe PMC
• Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.#666075NCBI PubMed Central
• Challenges and Opportunities for the Large-Scale Chemoenzymatic Glycoengineering of Therapeutic N-Glycosylated Monoclonal Antibodies#682936Apollo
• Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment#827009ClinicalTrials.gov
• Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients#827072ClinicalTrials.gov
• Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis#883173ClinicalTrials.gov
• Multi-modal feature learning to prioritize ADCs with favorable half-life in mice.#29698PubMed
• Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence#363852Gestión del Repositorio Documental de la Universidad de Salamanca
• Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110#804073ClinicalTrials.gov
• Comparative Analysis of Two Therapeutic Strategies in Patients With Spondyloarthritis Treated With Anti-tnf Biologics#845398ClinicalTrials.gov
• Structural insights into single-pass transmembrane receptor GC-A activation by distinct antihypertensive antibodies#657814Cornell eCommons
• Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.#298805NCBI PubMed Central
• Structural and Functional Determinants of ARIA-H Risk in Anti-Amyloid Monoclonal Antibodies: A Comparative Mechanistic Framework for Alzheimer's Immunotherapy Development.#610430NCBI PubMed Central
• Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma#889786ClinicalTrials.gov
• Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties.#170809PubMed
• A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV#208266ClinicalTrials.gov
• RSV prophylactics for pediatric populations: A product review and meta-analysis of real-world effectiveness#478502Europe PMC
• DyAb: sequence-based antibody design and property prediction in a low-data regime.#615980PubMed
• Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer#865882ClinicalTrials.gov
• Effectiveness and Tolerability of Eptinezumab#918601ClinicalTrials.gov
• Multidimensional Assessment of Chronic Pain in Severe Haemophilia A#969678ClinicalTrials.gov
• Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis#1010762ClinicalTrials.gov
• Cost-effectiveness of strategies using preventive interventions to protect infants in Chile from respiratory syncytial virus#637321Repositorio Universidad del Desarrollo
• Real-world effectiveness of onabotulinumtoxinA as first-line treatment in chronic migraine and sequential transition to anti-CGRP monoclonal antibodies: a retrospective multicenter study.#295198NCBI PubMed Central
• Human monoclonal antibodies with different fine-specificity for digoxin derivatives: Cloning of heavy and light chain variable region sequences#644883Lund University Publications
• Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis#810440ClinicalTrials.gov
• Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia#861774ClinicalTrials.gov
• Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures.#9472PubMed
• Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants.#823908Repisalud
• Novel CD20 Monoclonal Antibodies For Lymphoma Therapy#412863OpenCitations
• Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases#676952HAL (France)
• Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)#912779ClinicalTrials.gov
• A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available#1046580ClinicalTrials.gov
• A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria#892748ClinicalTrials.gov
• What is new on the horizon for the biologics world: New kids of the block – WAO state of art#971325IRIS